By Joshua E. Schimmer of Piper Jaffray With global markets being roiled by the apparently xenophobic and nationalistic fueled UK Brexit ‘Leave’ vote and …
The biotechnology sector has experienced a big rally in recent weeks. Uncoincidentally, the rally started right at major support, as seen on the first chart …
By Lawrence Katzenstein Since the 12 member states signed the TPP text agreement at the beginning of October we are still within the mandated …
What an insane end of the week we just had, especially with the Biotech sector late in the week. We saw a multitude …
Might Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) finally be bought?
As it stands now, U.S.
It’s no secret that biotech has been on an incredible run over the past several years. In fact, as we pointed out late last month, …
Volatility reigned in January on elevated volume as stock investors shifted their focus from global events to U.S.
Last week, the S&P 500 put an end to its streak of weekly losses, despite giving back some gains on Friday. Thursday provided …
